Bronchiolitis in children: diagnosis and management (NG9)Product type:GuidanceProgramme:NICE guidelineLast updated: 9 August 2021Published: 1 June 2015
Camlipixant for treating refractory or unexplained chronic cough [ID6722]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Cough (acute): antimicrobial prescribing (NG120)Product type:GuidanceProgramme:NICE guidelinePublished: 7 February 2019
FebriDx for C-reactive protein and myxovirus resistance protein A testingStatus:Topic prioritisationProgramme:Diagnostics guidanceExpected publication date: TBC
Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal) (TA969)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 April 2024
Isavuconazol for treating invasive aspergillosis or mucormycosis in people 1 to 17 years [TSID12284]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
Nitazoxanide for treating the common cold in people 12 years and over [ID4049]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
O2Matic pro 100 (MT746)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management (NG237)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 September 2025Published: 31 October 2023